Get started
State Street SPDR S&P Pharmaceuticals ETFState Street SPDR S&P Pharmaceuticals ETFState Street SPDR S&P Pharmaceuticals ETF

State Street SPDR S&P Pharmaceuticals ETF

No trades
OverviewAnalysisHoldingsNewsIdeasMindsTechnicalsSeasonalsOptions

Trade ideas

S&P Pharmaceutical Sector: A Prescription for Growth● The S&P Pharmaceutical sector has great potential for growth. ● The weekly chart shows that after breaking out of the Symmetrical Triangle Pattern, the ETF had a short period of consolidation and is now ready for a rise. ● The daily chart also indicates a Cup & Handle Pattern, with the price trending upward post-breakout. As the industry revives, certain stocks are ready to achieve similar success Key stocks to watch: Hims & Hers NYSE:HIMS ● The price has broken the trendline resistance with high volume. ● More upward movement is likely to follow. Crinetics Pharmaceuticals NASDAQ:CRNX ● Mirrors HIMS' chart pattern. ● Poised for robust growth after breakout.
AMEX:XPHLong
by NaranjCapital
XPH | Pharmaceuticals to Outperform- Price is breaking minor falling wedge pattern on strong volume - Pharmaceutical stocks have lagged the broader market in the past year and have not been so inexpensive relative to the S&P 500 in at least 20 years - As the healthcare sector is starting to out perform the overall market, I have been locking in gains on some cyclical stocks and positioning more defensive - I expect pharmaceuticals to outperform the market and sector in the short term as investor seek value in a richly priced stock market
AMEX:XPH
by ConnerM500
ETFs potential BUYS -XPH-EIDO-EUO-XBI-BIBFor Monday’s open, 5 ETF's are potential buys under my rules for Pullback Strategy. This strategy identifies oversold ETFs and takes advantage of the tendency for prices to revert to the mean in the short term. The ETFs set up as potential buys for Monday are listed in the table below: XPH -SPDR S&P Pharmaceuticals EIDO - Indonesia Invstble Mkt Idx MSCI EUO - Ultrashort Euro Proshares XBI - SPDR S&P Biotech BIB - Ultra Nasdaq Biotechnology Prosh
AMEX:XPHLong
by MIA_BLOG